InsiderSignal.AI

InsiderSignal.ai

VRTX - Vertex Pharmaceuticals Inc / Ma

Insider Sale by Ambrose Kristen (SVP, Chief Accounting Officer)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

2 days ago, Ambrose Kristen, serving as SVP, Chief Accounting Officer at Vertex Pharmaceuticals Inc / Ma (VRTX), sold 223 shares at $486.35 per share, for a total transaction value of $108,456.00. Following this transaction, Ambrose Kristen now holds 6,981 shares of VRTX.

This sale represents a 3.00% decrease in Ambrose Kristen's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, February 25, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, February 26, 2026, 1 day after the trade was made.

Vertex Pharmaceuticals Inc / Ma operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Ambrose Kristen

Ambrose Kristen

SVP, Chief Accounting Officer

Kristen C. Ambrose is the Senior Vice President and Chief Accounting Officer at Vertex Pharmaceuticals Inc. (VRTX), a role she has held since 2021.[[1]](https://www.zoominfo.com/p/Kristen-Ambrose/3463866350)[[2]](https://theorg.com/org/vertex-pharmaceuticals/org-chart/kristen-ambrose)[[4]](https://www.marketscreener.com/insider/KRISTEN-AMBROSE-A3FW4B/) In this position, she oversees a team of approximately 130 professionals in financial leadership and corporate accounting.[[2]](https://theorg.com/org/vertex-pharmaceuticals/org-chart/kristen-ambrose) As of 2026, she is approximately 49 years old.[[6]](https://www.morningstar.com/stocks/xnas/vrtx/executive) Ambrose recently engaged in insider trading activity, selling 1,376 shares of VRTX stock on February 11, 2025, at an average price of $459.83 per share for a total of $632,726 under a pre-established trading plan, leaving her with 9,953 shares directly held after additional transactions.[[3]](https://www.secform4.com/insider-trading/1856587.htm)[[5]](https://www.investing.com/news/insider-trading-news/vertex-pharmaceuticals-svp-ambrose-sells-shares-for-632726-93CH-3865821) Prior to her current role, she held other positions, though specific earlier career details are not detailed in available sources.[[4]](https://www.marketscreener.com/insider/KRISTEN-AMBROSE-A3FW4B/)

View full insider profile →

Trade Price

$486.35

Quantity

223

Total Value

$108,456.00

Shares Owned

6,981

Trade Date

Wednesday, February 25, 2026

2 days ago

SEC Filing Date

Thursday, February 26, 2026

Filed 1 day after trade

HEALTHCAREBIOTECHNOLOGY

About Vertex Pharmaceuticals Inc / Ma

Company Overview

No company information available
View news mentioning VRTX

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4326452

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

Create Free AccountLearn More

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime